The information contained in this website does not and is not meant to constitute a solicitation of a proxy within the meaning of applicable securities laws. Although the MindMed Shareholders for Accountability believe that they may have to call for a new meeting of shareholders to reconsider the business before the Annual Meeting, there is currently no record or meeting date set for a new meeting and shareholders are not being asked at this time to execute a proxy in favour of the MindMed Shareholders for Accountability. In connection with any new meeting, the MindMed Shareholders for Accountability may file a dissident information circular in due course in compliance with applicable securities laws.
Notwithstanding the foregoing, the MindMed Shareholders for Accountability are voluntarily providing the disclosure required under section 9.2(4) of National Instrument 51-102 – Continuous Disclosure Obligations and section 150(1.2) of the Canada Business Corporations Act applicable to public broadcast solicitations.
The information contained herein and any solicitation made by the MindMed Shareholders for Accountability in advance of a new meeting is, or will be, as applicable, made by the MindMed Shareholders for Accountability and not by or on behalf of the management of the Corporation. All costs incurred for any solicitation will be borne by the MindMed Shareholders for Accountability, provided that, subject to applicable law, the MindMed Shareholders for Accountability may in certain circumstances seek reimbursement from the Corporation of the MindMed Shareholders for Accountability’s out-of-pocket expenses, including proxy solicitation expenses and legal fees, incurred in connection with a new meeting.
The MindMed Shareholders for Accountability are not soliciting proxies in connection with a new meeting at this time. The MindMed Shareholders for Accountability may engage the services of one or more agents and authorize other persons to assist in soliciting proxies on behalf of the MindMed Shareholders for Accountability. Any solicitation of proxies by or on behalf of the MindMed Shareholders for Accountability, including by any agent, will be done primarily by mail, supplemented by telephone, internet, electronic communication or other means of contact, pursuant to a dissident information circular or by way of public broadcast, including through press releases, speeches or publications and by any other manner permitted under Canadian corporate and securities laws. Any such proxies may be revoked by instrument in writing executed by a shareholder or by his or her attorney authorized in writing or, if the shareholder is a body corporate, by an officer or attorney thereof duly authorized or by any other manner permitted by law.
The registered address of Mind Medicine (MindMed) Inc. (referred to as MindMed herein) is located at One World Trade Center, Suite 8500, New York, New York 10007.